CLSD icon

Clearside Biomedical
CLSD

Overview Fund Activity

50 hedge funds and large institutions have $114M invested in Clearside Biomedical in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-3
Holders Change %
-5.66%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
18
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$26.1M
2
GCP
2
GSA Capital Partners
United Kingdom
$561K
3
BlackRock
3
BlackRock
New York
$11.9M
4
FPC
4
Falcon Point Capital
California
$315K
5
WS
5
Wedbush Securities
California
$256K

Top Sellers

1
AIC
1
AWM Investment Company
New York
$893K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$0
3
Deutsche Bank
3
Deutsche Bank
Germany
$309K
4
GIP
4
Granite Investment Partners
California
$533K
5
HCM
5
Highbridge Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Renaissance Technologies
51
Renaissance Technologies
New York
– -$731K -80,200 Closed
HCM
52
Highbridge Capital Management
New York
– -$164K -18,006 Closed
PPA
53
Parametric Portfolio Associates
Washington
– -$122K -13,428 Closed
Citadel Advisors
54
Citadel Advisors
Florida
– -$117K -12,881 Closed
JPMorgan Chase & Co
55
JPMorgan Chase & Co
New York
– -$32K -3,471 Closed
PAM
56
Panagora Asset Management
Massachusetts
– -$9K -1,038 Closed
Creative Planning
57
Creative Planning
Kansas
– -$9K -1,000 Closed
1 2
3